Why the study?
Does ambulatory blood pressure monitoring improve the prediction of cardiovascular events and mortality compared to office blood pressure measurement in patients with chronic renal diseases?
Population
Patients with chronic renal diseases (uraemic patients) and hypertension
Comparison
Ambulatory blood pressure monitoring (ABPM) vs Clinical (office) blood pressure measurement
Design
Review
Authors
Loading...
May refine CV risk stratification in CKD; extends cohort data but leaves outcome trials open.
Does ambulatory blood pressure monitoring improve the prediction of cardiovascular events and mortality compared to office blood pressure measurement in patients with chronic renal diseases?
Ambulatory blood pressure monitoring provides superior prognostic value for cardiovascular risk compared to office blood pressure, supporting its routine use in patients with renal disease who frequently exhibit abnormal diurnal BP variability.
Adrian Covic (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: